Change search
ReferencesLink to record
Permanent link

Direct link
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Pharmacology.
Show others and affiliations
2010 (English)In: British Journal of Pharmacology, ISSN 0007-1188, E-ISSN 1476-5381, Vol. 160, no 3, 549-560 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND AND PURPOSE: Inhibitors of fatty acid amide hydrolase (FAAH), the enzyme responsible for the metabolism of the endogenous cannabinoid (CB) receptor ligand anandamide (AEA), are effective in a number of animal models of pain. Here, we investigated a series of isoflavones with respect to their abilities to inhibit FAAH. EXPERIMENTAL APPROACH: In vitro assays of FAAH activity and affinity for CB receptors were used to characterize key compounds. In vivo assays used were biochemical responses to formalin in anaesthetized mice and the 'tetrad' test for central CB receptor activation. KEY RESULTS: Of the compounds tested, biochanin A was adjudged to be the most promising. Biochanin A inhibited the hydrolysis of 0.5 microM AEA by mouse, rat and human FAAH with IC(50) values of 1.8, 1.4 and 2.4 microM respectively. The compound did not interact to any major extent with CB(1) or CB(2) receptors, nor with FAAH-2. In anaesthetized mice, URB597 (30 microg and biochanin A (100 microg both inhibited the spinal phosphorylation of extracellular signal-regulated kinase produced by the intraplantar injection of formalin. The effects of both compounds were significantly reduced by the CB(1) receptor antagonist/inverse agonist AM251 (30 microg Biochanin A (15 i.v.) did not increase brain AEA concentrations, but produced a modest potentiation of the effects of 10 i.v. AEA in the tetrad test. CONCLUSIONS AND IMPLICATIONS: It is concluded that biochanin A, in addition to its other biochemical properties, inhibits FAAH both in vitro and peripherally in vivo.

Place, publisher, year, edition, pages
Wiley , 2010. Vol. 160, no 3, 549-560 p.
Keyword [en]
fatty acid amide hydrolase, pain, cannabinoid, isoflavones, biochanin A, anandamide
National Category
Pharmacology and Toxicology
URN: urn:nbn:se:umu:diva-35622DOI: 10.1111/j.1476-5381.2010.00716.xISI: 000277914700012PubMedID: 20590565OAI: diva2:345718
Available from: 2010-08-26 Created: 2010-08-26 Last updated: 2011-04-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Thors, LFowler, Christopher J
By organisation
In the same journal
British Journal of Pharmacology
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 28 hits
ReferencesLink to record
Permanent link

Direct link